Haleon (HLN) Consolidated Net Income (2021 - 2023)
Haleon (HLN) posted Consolidated Net Income of $1.1 billion for Q4 2023, up 175.2% on a QoQ basis from $394.2 million in Q2 2023, and up 57.02% year-over-year from $690.9 million in Q4 2022.
Haleon (HLN) Consolidated Net Income (2021 - 2023) Analysis & Trends
Haleon's Consolidated Net Income history runs 3 years deep, the most recent figure standing at $1.1 billion for Q4 2023.
- Quarterly Consolidated Net Income rose 57.02% year-over-year to $1.1 billion in Q4 2023, while the trailing twelve-month figure through Dec 2025 was $1.1 billion (down 26.65% YoY) and the FY2025 annual result came in at $2.2 billion, up 66.62% from the prior year.
- Consolidated Net Income was $1.1 billion for Q4 2023 at Haleon, up from $394.2 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $1.2 billion in Q4 2021 and bottomed at $394.2 million in Q2 2023.
- A 3-year average of $760.5 million and a median of $680.3 million in 2022 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2022 — Consolidated Net Income slumped 43.18% — and 2023, when it surged 57.02%.
- Haleon's Consolidated Net Income stood at $1.2 billion in 2021, then slumped by 43.18% to $690.9 million in 2022, then jumped by 57.02% to $1.1 billion in 2023.
- Business Quant data shows HLN's Consolidated Net Income at $1.1 billion in Q4 2023, $394.2 million in Q2 2023, and $507.5 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -22.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.08 Bn |
| Jun 30, 2023 | 394.18 Mn |
| May 3, 2023 | 507.45 Mn |
| Dec 31, 2022 | 690.85 Mn |
| Sep 20, 2022 | 669.82 Mn |
| Dec 31, 2021 | 1.22 Bn |